Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus

The evidence suggests that combination therapy for benign prostatic hyperplasia (BPH)-lower urinary tract symptoms (LUTS) using an α-blocker and a 5α-reductase inhibitor has become well accepted. The combination of daily tadalafil and an α-blocker has also demonstrated benefit. This paper addresses...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkelany, Osama O, Owen, Ryan C, Kim, Edward D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386768/
https://www.ncbi.nlm.nih.gov/pubmed/25848297
http://dx.doi.org/10.2147/TCRM.S80353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386768/
https://www.ncbi.nlm.nih.gov/pubmed/25848297
http://dx.doi.org/10.2147/TCRM.S80353

Ejemplares similares